ProfileGDS4718 / 230082_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 84% 88% 64% 86% 89% 75% 69% 84% 90% 88% 85% 91% 81% 68% 68% 75% 85% 67% 62% 51% 88% 90% 89% 88% 86% 71% 89% 69% 88% 60% 73% 57% 91% 88% 55% 66% 76% 83% 89% 56% 82% 71% 67% 61% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.4101884
GSM549102patient 115, normal, homogenized [OPG study]8.761288
GSM549104patient 119, normal, homogenized [OPG study]6.4756864
GSM549108patient 138, normal, homogenized [OPG study]8.5093786
GSM549119patient 077, normal, homogenized [OPG study]8.9975589
GSM549133patient 032, cancer, homogenized [OPG study]7.4206775
GSM549139patient 042, cancer, homogenized [OPG study]6.8078669
GSM549099patient 107, normal, homogenized [OPG study]8.2714784
GSM549109patient 139, normal, homogenized [OPG study]9.1786790
GSM549110patient 046, normal, homogenized [OPG study]8.8591488
GSM549114patient 063, normal, homogenized [OPG study]8.5400485
GSM549122patient 082, normal, homogenized [OPG study]9.4299391
GSM549134patient 033, cancer, homogenized [OPG study]8.0352181
GSM549136patient 036, cancer, homogenized [OPG study]6.7337968
GSM549140patient 044, cancer, homogenized [OPG study]6.7254868
GSM549111patient 047, normal, homogenized [OPG study]7.4020775
GSM549113patient 057, normal, homogenized [OPG study]8.555885
GSM549132patient 031, cancer, homogenized [OPG study]6.6222767
GSM549137patient 038, cancer, homogenized [OPG study]6.2782462
GSM549142patient 047, cancer, homogenized [OPG study]5.7108851
GSM549100patient 110, normal, homogenized [OPG study]8.8130388
GSM549107patient 135, normal, homogenized [OPG study]9.3443190
GSM549115patient 068, normal, homogenized [OPG study]9.2028889
GSM549116patient 072, normal, homogenized [OPG study]8.8934588
GSM549120patient 078, normal, homogenized [OPG study]8.6187486
GSM549131patient 030, cancer, homogenized [OPG study]7.0352871
GSM549118patient 074, normal, homogenized [OPG study]9.0690889
GSM549129patient 027, cancer, homogenized [OPG study]6.8640169
GSM549123patient 088, normal, homogenized [OPG study]8.9791788
GSM549124patient 006, cancer, homogenized [OPG study]6.1167860
GSM549126patient 015, cancer, homogenized [OPG study]7.0982873
GSM549128patient 025, cancer, homogenized [OPG study]5.9174157
GSM549103patient 117, normal, homogenized [OPG study]9.2685991
GSM549117patient 073, normal, homogenized [OPG study]9.0366988
GSM549138patient 041, cancer, homogenized [OPG study]5.8095655
GSM549141patient 045, cancer, homogenized [OPG study]6.5791666
GSM549130patient 028, cancer, homogenized [OPG study]7.397776
GSM549101patient 111, normal, homogenized [OPG study]8.107183
GSM549105patient 128, normal, homogenized [OPG study]9.0650789
GSM549106patient 134, normal, homogenized [OPG study]5.8434556
GSM549112patient 048, normal, homogenized [OPG study]8.1081382
GSM549125patient 011, cancer, homogenized [OPG study]6.9193971
GSM549127patient 024, cancer, homogenized [OPG study]6.7340467
GSM549135patient 035, cancer, homogenized [OPG study]6.1505661